1 / 4

Arbro Launches Nanotechnology Based Bioavailable Curcumin

Arbro Pharmaceuticals partnered with Jamia Hamdard to carry out research to develop a novel formulation which can overcome curcumin's poor bioavailability. The development project was jointly funded by Arbro and the Department of Science and Technology Government of India under its DPRP scheme.

snec30
Download Presentation

Arbro Launches Nanotechnology Based Bioavailable Curcumin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Arbro Launches Nanotechnology Based Bioavailable Curcumin New Delhi : Arbro Pharmaceuticals has launched SNEC30, a patented highly bioavailable Self Nano Emulsifying Curcumin formulation in 30 mg dose. Curcumin is the active ingredient of turmeric/Haldi which has been widely used in traditional medicine and home remedies in India for hundreds of years. Clinical research conducted over the last 25 years has shown curcumin to be effective in various diseases like cancer, pain, inflammation, arthritis, ulcers, psoriasis, arteriosclerosis, diabetes and many more pro-inflammatory conditions. Despite of its effectiveness against so many conditions, scientists have ?elie?ed that ?ur?u?i?’s true pote?tial has ?ee? li?ited ?y its poor bioavailability which is caused by its poor solubility and extensive pre- systemic metabolism.

  2. Arbro Pharmaceuticals partnered with Jamia Hamdard to carry out research to develop a novel formulation which can overcome ?ur?u?i?’s poor ?ioa?aila?ility. The de?elop?e?t proje?t ?as jointly funded by Arbro and the Department of Science and Technology Government of India under its DPRP scheme. SNEC30 is the outcome of this joint development and is based on a novel self nano emulsifying drug delivery system for which patents have been filed and the US patent has been granted.

  3. ?There has ?ee? tre?e?dous i?terest i? the therapeuti? potential of curcumin but its poor bioavailability was a limiting factor, our research group together with Arbro took the challenge and applied nanotechnology to overcome this limitation and achieve highest ever ?ioavaila?ility for ?ur?u?i?? said Dr. Kanchan Kohli, Asst. Prof Faculty of Pharmacy, Jamia Hamdard who is one of the main inventors of the technology. ?Just 30 ?g of ?ur?u?i? i? o?e ?apsule of “NEC30 has shown higher blood levels than what can be achieved by consuming the curcumin content of 1 kg of raw haldi/tur?eri?? said Mr. Vijay Kumar Arora, Managing Director, Arbro Pharmaceuticals. Arbro pharmaceuticals is a 30-year-old research oriented company with its own research and development, testing and manufacturing facilities. Arbro has been manufacturing and exporting more than hundred formulations under its own brand name to more than 10 countries.

  4. For More Information You Can Contact : Email Address: marketing@snec30.com Contact Number: 011-42880806 Website: www.snec30.com Address: DSM-129 1st Floor DLF Commercial Tower Shivaji Marg, Moti Nagar, New Delhi 110015

More Related